Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 8/20 | 0.76 |
| ▸ | RAB9A | P51151 | 8/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.76 |
| ▸ | TP53 | P04637 | 3/20 | 0.76 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.76 |
| ▸ | PKM | P14618 | 1/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.76 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.72 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.69 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.69 |
| ▸ | KCNK9 | Q9NPC2 | 2/20 | 0.64 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.64 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.60 |
| ▸ | RELA | Q04206 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
| ▸ | PLAU | P00749 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10055020 | 0.90 | NPC1 (0.94) | NPC1RAB9AALDH1A1TP53SMN1; SMN2 | |
| SCHEMBL4256368 | 0.87 | NPC1 (1.00) | NPC1RAB9AALDH1A1TP53SMN1; SMN2 | |
| SCHEMBL12509568 | 0.85 | RAB9A (0.55) | NPC1RAB9AALDH1A1TP53SMN1; SMN2 | |
| SCHEMBL31179863 | 0.84 | NPC1 (0.83) | NPC1RAB9AALDH1A1TP53SMN1; SMN2 | |
| SCHEMBL4252397 | 0.84 | NPC1 (0.83) | NPC1RAB9AALDH1A1TP53SMN1; SMN2 | |
| SCHEMBL29800540 | 0.84 | NPC1 (1.00) | NPC1RAB9AALDH1A1TP53SMN1; SMN2 | |
| SCHEMBL2176828 | 0.84 | NPC1 (1.00) | NPC1RAB9AALDH1A1TP53SMN1; SMN2 | |
| SCHEMBL4248632 | 0.83 | RAB9A (0.81) | NPC1RAB9AALDH1A1TP53SMN1; SMN2 | |
| SCHEMBL4250977 | 0.83 | NPC1 (0.81) | NPC1RAB9AALDH1A1TP53SMN1; SMN2 | |
| SCHEMBL94789 | 0.83 | NPC1 (0.81) | NPC1RAB9AALDH1A1TP53SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110171739-A1 | LIGANDS FOR AGGREGATED TAU MOLECULES | WISTA LABORATORIES LTD. | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110171739-A1 | LIGANDS FOR AGGREGATED TAU MOLECULES | MAPT, PRNP, MAP4 | NPC1 1265/4885RAB9A 2622/4885ALDH1A1 2058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.